Etoposide

   
Google
 
Web NewDrugInformation.com

Etoposide


Drug - Etoposide
The trade name of the product as shown on the labeling.

Dosage - INJECTABLE; INJECTION
The product dosage form and route separated by a semi-colon.

Active Ingredient(s) - Etoposide
Multiple ingredients are in alphabetical order.

Strength - 20MG/ML
The potency of the active ingredient(s), Etoposide. May repeat for multiple part products.

Applicant - SICOR PHARMS
The firm name holding legal responsibility for Etoposide. The firm name is condensed to a maximum twenty character unique string.

New Drug Application (NDA) Number - 074284
The FDA assigned number to Etoposide. Format is nnnnnn.

Product Number - 001
The FDA assigned number to identify Etoposide. Each strength is a separate product. May repeat for multiple part products. Format is nnn.

Therapeutic Equivalence (TE) Code - AP
The TE Code indicates the therapeutic equivalence rating of generic to innovator Rx products.

Approval Date - Feb 10, 1994
The date Etoposide was approved as stated in the FDA approval letter to the applicant. The format is Mmm dd, yyyy. Products approved prior to the January 1, 1982 contain the phrase: "Approved prior to Jan 1, 1982".

Reference Listed Drug (RLD) - No
The pioneer or innovator of Etoposide. The RLD identifies the product Abbreviated New Drug Applications (ANDA) use as a reference. Format is Yes or No.

Type - RX
The group or category of approved drugs Etoposide is in. Format is RX, OTC, DISCN.

Applicant Full Name - Sicor Pharmaceuticals Inc
The full name of the firm holding legal responsibility for the new application of Etoposide.

Etoposide